Tower Research Capital LLC (TRC) - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is and the CUSIP is 88338N206. A total of 56 filers reported holding THERAPEUTICSMD INC in Q2 2022. The put-call ratio across all filers is 2.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q3 2023$2,836
+133.4%
939
+218.3%
0.00%
Q2 2023$1,215295
+1538.9%
0.00%
Q1 2023$018
-55.0%
0.00%
Q3 2022$0
-100.0%
40
-80.0%
0.00%
Q2 2022$2,0002000.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q2 2022
NameSharesValueWeighting ↓
Rubric Capital Management LP 791,831$7,879,0000.41%
PenderFund Capital Management Ltd. 24,410$313,0000.09%
EQUITEC PROPRIETARY MARKETS, LLC 16,500$164,0000.05%
EQUITEC PROPRIETARY MARKETS, LLC 12,600$125,0000.04%
Asset Management Group, Inc. 14,701$146,0000.04%
EQUITEC PROPRIETARY MARKETS, LLC 11,455$114,0000.03%
Ergoteles LLC 84,700$843,0000.02%
XR Securities LLC 41,200$66,0000.02%
State of Wyoming 2,932$29,0000.02%
CSS LLC/IL 21,782$217,0000.01%
View complete list of THERAPEUTICSMD INC shareholders